| David Charles Alexander Fisher, MD | |
|
1025 Morehead Medical Dr, Ste 200, Charlotte, NC 28204-2963 | |
| (704) 446-6810 | |
| Not Available |
| Full Name | David Charles Alexander Fisher |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 20 Years |
| Location | 1025 Morehead Medical Dr, Charlotte, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124216502 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 2009-01905 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carolinas Medical Center/behav Health | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Medical Center | 4789597477 | 735 |
| The Charlotte-mecklenburg Hospital Authority | 2961310685 | 488 |
News Archive
People with attractive faces are often seen as more trustworthy, socially competent, better adjusted, and more capable in school and work.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.
Postmenopausal women who are not identified by traditional cardiovascular risk factors, could benefit from a simple blood test to show their white blood cell (WBC) count which may predict cardiovascular events and risk of death.
Often marketed as symbols of independence, freedom and pleasure for women, cigarettes are highly addictive, expensive and detrimental to the health of smokers and those who share their environment. By 2025, the World Health Organization predicts that 20% of women will smoke, compared to 12% today. In Canada, over 17,000 women die from smoking related causes each year.
› Verified 4 days ago
| Entity Name | Carolinas Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774333 PECOS PAC ID: 4789597477 Enrollment ID: O20031110000116 |
News Archive
People with attractive faces are often seen as more trustworthy, socially competent, better adjusted, and more capable in school and work.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.
Postmenopausal women who are not identified by traditional cardiovascular risk factors, could benefit from a simple blood test to show their white blood cell (WBC) count which may predict cardiovascular events and risk of death.
Often marketed as symbols of independence, freedom and pleasure for women, cigarettes are highly addictive, expensive and detrimental to the health of smokers and those who share their environment. By 2025, the World Health Organization predicts that 20% of women will smoke, compared to 12% today. In Canada, over 17,000 women die from smoking related causes each year.
› Verified 4 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
People with attractive faces are often seen as more trustworthy, socially competent, better adjusted, and more capable in school and work.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.
Postmenopausal women who are not identified by traditional cardiovascular risk factors, could benefit from a simple blood test to show their white blood cell (WBC) count which may predict cardiovascular events and risk of death.
Often marketed as symbols of independence, freedom and pleasure for women, cigarettes are highly addictive, expensive and detrimental to the health of smokers and those who share their environment. By 2025, the World Health Organization predicts that 20% of women will smoke, compared to 12% today. In Canada, over 17,000 women die from smoking related causes each year.
› Verified 4 days ago
| Entity Name | The Charlotte-mecklenburg Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669738829 PECOS PAC ID: 2961310685 Enrollment ID: O20100309000605 |
News Archive
People with attractive faces are often seen as more trustworthy, socially competent, better adjusted, and more capable in school and work.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.
Postmenopausal women who are not identified by traditional cardiovascular risk factors, could benefit from a simple blood test to show their white blood cell (WBC) count which may predict cardiovascular events and risk of death.
Often marketed as symbols of independence, freedom and pleasure for women, cigarettes are highly addictive, expensive and detrimental to the health of smokers and those who share their environment. By 2025, the World Health Organization predicts that 20% of women will smoke, compared to 12% today. In Canada, over 17,000 women die from smoking related causes each year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Charles Alexander Fisher, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | David Charles Alexander Fisher, MD 1025 Morehead Medical Dr, Ste 200, Charlotte, NC 28204-2963 Ph: (704) 446-6810 |
News Archive
People with attractive faces are often seen as more trustworthy, socially competent, better adjusted, and more capable in school and work.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Microscopic bacteria, which are present in all humans, cluster together and form communities in different parts of the body, such as the gut, lungs, nose and mouth.
Postmenopausal women who are not identified by traditional cardiovascular risk factors, could benefit from a simple blood test to show their white blood cell (WBC) count which may predict cardiovascular events and risk of death.
Often marketed as symbols of independence, freedom and pleasure for women, cigarettes are highly addictive, expensive and detrimental to the health of smokers and those who share their environment. By 2025, the World Health Organization predicts that 20% of women will smoke, compared to 12% today. In Canada, over 17,000 women die from smoking related causes each year.
› Verified 4 days ago
Dr. Michael Steven Gart, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1915 Randolph Rd, Charlotte, NC 28207 Phone: 704-323-2000 | |
Dr. Ryan Michael Garcia, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1915 Randolph Rd, Charlotte, NC 28207 Phone: 704-323-2000 | |
Dr. Miguel Angel Yanez, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5815 Blakeney Park Dr Ste 100, Charlotte, NC 28277 Phone: 704-542-2220 Fax: 704-572-3304 | |
Gregory Allen Mantooth, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5815 Blakeney Park Dr Ste 100, Charlotte, NC 28277 Phone: 704-542-2220 Fax: 704-542-3304 | |
Michael H Carstens, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1719 South Blvd # B, Charlotte, NC 28203 Phone: 704-375-2955 Fax: 704-377-2766 | |
Dr. Robin J Hennessy, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 315 Arlington Ave, Suite 2003, Charlotte, NC 28203 Phone: 704-444-3301 |